Craft

RxSight

Stock Price

$52.2

2024-10-29

Market Capitalization

$2.1 B

2024-10-29

Revenue

$134.5 M

FY, 2025

RxSight Summary

Company Summary

Overview
RxSight (formerly known as Calhoun Vision) is an ophthalmic medical technology company that develops adjustable intraocular lenses (IOL) that are customized after cataract surgery. It uses a proprietary light treatment that produces precise modifications in lens curvature. The Light Adjustable Lens (RxLAL) enables doctors and patients to optimize vision after cataract surgery through an office-based IOL enhancement.
Type
Public
Status
Active
Founded
1997
HQ
Aliso Viejo, CA, US | view all locations
Website
https://www.rxsight.com/
Cybersecurity rating
Sectors

Key People

  • Ron Kurtz

    Ron Kurtz, President and CEO, Director

    • Eric Weinberg

      Eric Weinberg, Chief Commercial Officer

    • Ilya Goldshleger

      Ilya Goldshleger, Chief Operating Officer

    • Shelley Thunen

      Shelley Thunen, Chief Financial Officer

      LocationsView all

      1 location detected

      • Aliso Viejo, CA HQ

        United States

        100 Columbia

      RxSight Financials

      Summary Financials

      Revenue (Q1, 2026)
      $30.9M
      Gross profit (Q1, 2026)
      $23.5M
      Net income (Q1, 2026)
      ($15.9M)
      Cash (Q1, 2026)
      $17.6M
      EBIT (Q1, 2026)
      ($17.8M)

      Footer menu